Diphenylamine

Diphenylamine

SCHEMBL593267

NCCCC[C@H](N)C(=O)O.c1ccc(Nc2ccccc2)cc1

nearest known ligand 0.67

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

PPARDPTGS1PTGS2dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of Diphenylamine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ PTGS1 known ✓ P23219 1/20 0.44
▸ GSR P00390 1/20 0.67
▸ LTA4H P09960 3/20 0.59
▸ MMP2 P08253 2/20 0.52
▸ POLB P06746 1/20 0.51
▸ KMT2A Q03164 1/20 0.51
▸ TDP1 Q9NUW8 1/20 0.51
▸ DPP8 Q6V1X1 1/20 0.50
▸ DPP9 Q86TI2 1/20 0.50
▸ DPP7 Q9UHL4 1/20 0.50
▸ KIF11 P52732 3/20 0.46
▸ MMP9 P14780 1/20 0.46
▸ THRB P10828 1/20 0.45
▸ ALPI P09923 1/20 0.44
▸ PKM P14618 1/20 0.44
▸ XIAP P98170 1/20 0.44
▸ SLC7A5 Q01650 1/20 0.44
▸ NOS1 P29475 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Lysine SCHEMBL4305051 0.86 GSR (0.57) GSRLTA4HMMP2POLBKMT2A
Lysine SCHEMBL941017 0.86 GSR (0.57) GSRLTA4HMMP2POLBKMT2A
Lysine SCHEMBL9716604 0.86 GSR (0.57) GSRLTA4HMMP2POLBKMT2A
Lysine SCHEMBL28214073 0.86 GSR (0.91) GSRMMP2POLBKMT2ATDP1
Lysine SCHEMBL28249818 0.85 GSR (0.69) GSRLTA4HMMP2POLBKMT2A
Lysine SCHEMBL28249816 0.85 GSR (0.69) GSRLTA4HMMP2POLBKMT2A
Lysine SCHEMBL20303616 0.84 GSR (0.54) GSRLTA4HMMP2POLBKMT2A
Lysine SCHEMBL20303617 0.84 GSR (0.54) GSRLTA4HMMP2POLBKMT2A
Aminodiphenylmethane SCHEMBL23925166 0.83 GSR (0.67) GSRMMP2POLBKMT2ATDP1
Lysine SCHEMBL3907035 0.83 GSR (0.67) GSRLTA4HMMP2POLBKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8703167-B2 Coatings for implantable medical devices for controlled release of a hydrophilic drug and a hydrophobic drug ADVANCED CARDIOVASCULAR SYSTEMS, INC. (US) 2014-04-22 — — US claimed
WO-2007146001-A2 COATINGS FOR IMPLANTABLE MEDICAL DEVICES FOR CONTROLLED RELEASE OF A HYDROPHILIC DRUG AND A HYDROPHOBIC DRUG ABBOTT CARDIOVASCULAR SYSTEMS INC. (US) 2007-12-21 — — WO claimed
US-20070280991-A1 Coatings for implantable medical devices for controlled release of a hydrophilic drug and a hydrophobic drug ADVANCED CARDIOVASCULAR SYSTEMS, INC. 2007-12-06 — — US claimed
EP-1848470-A2 COATINGS FOR IMPLANTABLE MEDICAL DEVICES CONTAINING ATTRACTANTS FOR ENDOTHELIAL CELLS Abbott Cardiovascular Systems, Inc. (US) 2007-10-31 — — EP claimed
WO-2007097887-A2 COATINGS FOR IMPLANTABLE MEDICAL DEVICES CONTAINING ATTRACTANTS FOR ENDOTHELIAL CELLS ADVANCED CARDIOVASCULAR SYSTEMS, INC. (US) 2007-08-30 — — WO claimed
US-20070003589-A1 Coatings for implantable medical devices containing attractants for endothelial cells ADVANCED CARDIOVASCULAR SYSTEMS, INC. 2007-01-04 — — US claimed
WO-2006112932-A2 COATINGS FOR IMPLANTABLE MEDICAL DEVICES CONTAINING ATTRACTANTS FOR ENDOTHELIAL CELLS ADVANCED CARDIOVASCULAR SYSTEMS, INC. (US) 2006-10-26 — — WO claimed
US-8703167-B2 Coatings for implantable medical devices for controlled release of a hydrophilic drug and a hydrophobic drug ADVANCED CARDIOVASCULAR SYSTEMS, INC. (US) 2014-04-22 — — US disclosed
US-20120135131-A1 RGD PEPTIDE ATTACHED TO BIOABSORBABLE STENTS ADVANCED CARDIOVASCULAR SYSTEMS, INC. (US) 2012-05-31 — — US disclosed
US-8118863-B2 RGD peptide attached to bioabsorbable stents ABBOTT CARDIOVASCULAR SYSTEMS INC. (US) 2012-02-21 — — US disclosed
US-8114150-B2 RGD peptide attached to bioabsorbable stents ADVANCED CARDIOVASCULAR SYSTEMS, INC. (US) 2012-02-14 — — US disclosed
US-8062350-B2 RGD peptide attached to bioabsorbable stents ABBOTT CARDIOVASCULAR SYSTEMS INC. (US) 2011-11-22 — — US disclosed
US-7887572-B2 An implantable device having a bioactive pattern of pores loaded with protein of fibronectin, laminin 5, elastin, silk elastin, or collagen bonded by a spacer to an endothelialization promoter to form a biological conjugate; tissue engineering; stents; heart valves; vascular systems; drug delivery ADVANCED CARDIOVASCULAR SYSTEMS, INC. (US) 2011-02-15 — — US disclosed
US-20070293941-A1 RGD peptide attached to bioabsorbable stents ADVANCED CARDIOVASCULAR SYSTEMS, INC. 2007-12-20 — — US disclosed
US-20070280991-A1 Coatings for implantable medical devices for controlled release of a hydrophilic drug and a hydrophobic drug ADVANCED CARDIOVASCULAR SYSTEMS, INC. 2007-12-06 — — US disclosed
EP-1848470-A2 COATINGS FOR IMPLANTABLE MEDICAL DEVICES CONTAINING ATTRACTANTS FOR ENDOTHELIAL CELLS Abbott Cardiovascular Systems, Inc. (US) 2007-10-31 — — EP disclosed
WO-2007097887-A2 COATINGS FOR IMPLANTABLE MEDICAL DEVICES CONTAINING ATTRACTANTS FOR ENDOTHELIAL CELLS ADVANCED CARDIOVASCULAR SYSTEMS, INC. (US) 2007-08-30 — — WO disclosed
WO-2007070630-A2 IMPLANTABLE DEVICES FOR ACCELERATED HEALING ADVANCED CARDIOVASCULAR SYSTEMS, INC. (US) 2007-06-21 — — WO disclosed
US-20070003589-A1 Coatings for implantable medical devices containing attractants for endothelial cells ADVANCED CARDIOVASCULAR SYSTEMS, INC. 2007-01-04 — — US disclosed
WO-2006112932-A2 COATINGS FOR IMPLANTABLE MEDICAL DEVICES CONTAINING ATTRACTANTS FOR ENDOTHELIAL CELLS ADVANCED CARDIOVASCULAR SYSTEMS, INC. (US) 2006-10-26 — — WO disclosed
Send feedback